Psybio Therapeutics Corp (OP:PSYBF)

0.0001 UNCHANGED

Last Price Updated: 9:49 AM EST, Nov 7, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0001
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0001
Today's Range	0.0001 - 0.0001
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views ↗

June 08, 2023

Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably Massachusetts are seeing the decriminalization of natural substances...

Via Benzinga

EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' ↗

April 14, 2023

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental...

Via Benzinga

Performance

More News

Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More ↗

December 13, 2022

Via Benzinga

Psychedelics & Environmental Protection: Company Seeks Patents To Synthetically Produce Toad Venom ↗

December 12, 2022

Via Benzinga

Psychedelics Production Methods Expect Further IP Protection With 4 New Patents ↗

December 07, 2022

Via Benzinga

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project ↗

December 06, 2022

Via Benzinga

PsyBio Therapeutics Reports Interim Third Quarter 2022 Financial Results ↗

December 01, 2022

Via Benzinga

Yeast Produces Bread And Psilocybin, This Company Is Moving Into Clinical Trial Phase ↗

October 11, 2022

Via Benzinga

Most, But Not All, Psychedelics Companies Have Sufficient Liquidity ↗

September 06, 2022

Via Benzinga

DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results ↗

August 29, 2022

Via Benzinga

PsyBio Therapeutics Presents "How Genetically Modified Bacteria Can Yield Best-In-Class Psychedelics" At The Psychedelic Capital Conference ↗

April 29, 2022

Via Benzinga

Cannabis Movers & Shakers: Burns & Levinson, Water Ways, Chill Brands, Rubicon Organics ↗

January 24, 2022

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Via Benzinga

Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study ↗

September 27, 2021

Via Benzinga

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗

July 02, 2021

Via Benzinga

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗

June 30, 2021

Via Benzinga

Frequently Asked Questions

Is Psybio Therapeutics Corp publicly traded?

Yes, Psybio Therapeutics Corp is publicly traded.

What exchange does Psybio Therapeutics Corp trade on?

Psybio Therapeutics Corp trades on the OTC Traded

What is the ticker symbol for Psybio Therapeutics Corp?

The ticker symbol for Psybio Therapeutics Corp is PSYBF on the OTC Traded

What is the current price of Psybio Therapeutics Corp?

The current price of Psybio Therapeutics Corp is 0.0001

When was Psybio Therapeutics Corp last traded?

The last trade of Psybio Therapeutics Corp was at 11/07/24 09:49 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.